268 related articles for article (PubMed ID: 16463269)
21. Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study.
O'Sullivan MJ; Perlman EJ; Furman J; Humphrey PA; Dehner LP; Pfeifer JD
Hum Pathol; 2001 Oct; 32(10):1109-15. PubMed ID: 11679946
[TBL] [Abstract][Full Text] [Related]
22. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors.
Li Y; Tanaka K; Fan X; Nakatani F; Li X; Nakamura T; Takasaki M; Yamamoto S; Iwamoto Y
Cancer Lett; 2010 Aug; 294(1):57-65. PubMed ID: 20153576
[TBL] [Abstract][Full Text] [Related]
24. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
[TBL] [Abstract][Full Text] [Related]
25. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
Spahn L; Siligan C; Bachmaier R; Schmid JA; Aryee DN; Kovar H
Oncogene; 2003 Oct; 22(44):6819-29. PubMed ID: 14534527
[TBL] [Abstract][Full Text] [Related]
26. Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines.
Szuhai K; Ijszenga M; Tanke HJ; Rosenberg C; Hogendoorn PC
Cancer Genet Cytogenet; 2006 Apr; 166(2):173-9. PubMed ID: 16631476
[TBL] [Abstract][Full Text] [Related]
27. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
[TBL] [Abstract][Full Text] [Related]
28. Molecular detection of EWS-Ets fusion transcripts and their clinicopathologic significance in Ewing's sarcoma/peripheral primitive neuroectodermal tumor.
Wang H; Zheng J; Wang YP; Yang Y; You JF
Chin Med J (Engl); 2005 Aug; 118(16):1323-9. PubMed ID: 16157025
[TBL] [Abstract][Full Text] [Related]
29. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
30. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
[TBL] [Abstract][Full Text] [Related]
31. Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymes.
Hühn R; Staege MS; Hesse M; Liebig B; Burdach SE
Anticancer Res; 2009 Jun; 29(6):1901-8. PubMed ID: 19528446
[TBL] [Abstract][Full Text] [Related]
32. Periosteal Ewing sarcoma family of tumors of the femur confirmed by molecular detection of EWS-FLI1 fusion gene transcripts: a case report and review of the literature.
Hakozaki M; Hojo H; Tajino T; Yamada H; Kikuta A; Ito M; Sano H; Mochizuki K; Akaihata M; Kikuchi S; Abe M
J Pediatr Hematol Oncol; 2007 Aug; 29(8):561-5. PubMed ID: 17762498
[TBL] [Abstract][Full Text] [Related]
33. Detection of minimal bone marrow infiltration in patients with localized and metastatic Ewing sarcoma using RT-PCR.
Sumerauer D; Vícha A; Kucerová H; Kodet R; Housková J; Bedrnícek J; Eckschlager T
Folia Biol (Praha); 2001; 47(6):206-10. PubMed ID: 11768778
[TBL] [Abstract][Full Text] [Related]
34. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus E1A does not induce the Ewing tumor-associated gene fusion EWS-FLI1.
Kovar H; Fallaux FJ; Pribill I; Jugovic D; Bartl S; Ambros PF; Aryee DN; Wiegant JC; Hoeben RC
Cancer Res; 2000 Mar; 60(6):1557-60. PubMed ID: 10749123
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of P53 status in Ewing sarcoma.
de Alava E; Antonescu CR; Panizo A; Leung D; Meyers PA; Huvos AG; Pardo-Mindán FJ; Healey JH; Ladanyi M
Cancer; 2000 Aug; 89(4):783-92. PubMed ID: 10951341
[TBL] [Abstract][Full Text] [Related]
37. The Biology of Ewing sarcoma.
Riggi N; Stamenkovic I
Cancer Lett; 2007 Aug; 254(1):1-10. PubMed ID: 17250957
[TBL] [Abstract][Full Text] [Related]
38. Ewing's sarcoma oncoprotein EWS-FLI1: the perfect target without a therapeutic agent.
Uren A; Toretsky JA
Future Oncol; 2005 Aug; 1(4):521-8. PubMed ID: 16556028
[TBL] [Abstract][Full Text] [Related]
39. Phosphoproteomic profiling reveals IL6-mediated paracrine signaling within the Ewing sarcoma family of tumors.
Anderson JL; Titz B; Akiyama R; Komisopoulou E; Park A; Tap WD; Graeber TG; Denny CT
Mol Cancer Res; 2014 Dec; 12(12):1740-54. PubMed ID: 25092916
[TBL] [Abstract][Full Text] [Related]
40. Occasional involvement of the ovary in Ewing sarcoma.
Abir R; Feinmesser M; Yaniv I; Fisch B; Cohen IJ; Ben-Haroush A; Meirow D; Felz C; Avigad S
Hum Reprod; 2010 Jul; 25(7):1708-12. PubMed ID: 20472912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]